About this trial
This study evaluates whether re-sterilized (reprocessed) ablation catheters are as effective and safe as new ablation catheters when used for electrophysiological procedures. Adult patients scheduled for catheter ablation will be randomly assigned to undergo the procedure using either a new catheter or a re-sterilized catheter, with identical procedural techniques applied in both groups. The study will compare procedural efficiency, safety, costs, and environmental impact between the two approaches. The results may support more sustainable and cost-effective use of medical devices in cardiac electrophysiology.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥ 18 years
Indication for ablation according to current clinical guidelines
Written informed consent
Disqualifiers
Severe valvular heart disease
Significant structural heart disease that precludes (or makes ablation not feasible)
Pregnancy or breastfeeding
Life expectancy < 12 months
Trial design
Parallel
Treatments tested in this trial
Ablation - new
Procedure/SurgeryParticipants will undergo electrophysiological procedure (ablation). The intervention consists of the use a new ablation catheter. The key distinguishing feature of this intervention is the comparison of reprocessed versus new single-use catheters, while all other procedural aspects, including operator technique, energy delivery protocol, and peri-procedural care, are standardized and identical between groups.
Ablation - reprocessed
Procedure/SurgeryParticipants will undergo electrophysiological procedure (ablation). The intervention consists of the use of a reprocessed ablation catheter. The reprocessed catheter has undergone validated cleaning, resterilization, and functional testing in accordance with regulatory and safety standards prior to reuse. The key distinguishing feature of this intervention is the comparison of reprocessed versus new single-use catheters, while all other procedural aspects, including operator technique, energy delivery protocol, and peri-procedural care, are standardized and identical between groups.
Treatment groups
Trial outcomes
Primary outcomes
Ablation duration
Procedure duration, expressed in minutes, measured from groin puncture to completion of ablation.
Secondary outcomes
Acute Procedural Success
Successful completion of ablation defined as achievement of electrical isolation of the target tissue
Medical Waste Generated Per Procedure
Amount of medical waste generated per ablation procedure, expressed in kilograms.
Fluoroscopy Time
Total fluoroscopy time, expressed in minutes, recorded during the ablation procedure.
Radiation Dose (Dose-Area Product)
Radiation exposure expressed as dose-area product (DAP), automatically recorded during the ablation procedure.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Ivan Zeljkovic
Lead sponsor
University Hospital Dubrava
Sponsor institution
This trial is not recruiting at the moment. You can still explore other options: